Melissa K Schaefer1, Kiran M Perkins2, Joseph F Perz2. 1. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Electronic address: mschaefer@cdc.gov. 2. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, GA.
Abstract
OBJECTIVES: To summarize patient notifications resulting from unsafe injection practices by health care personnel in the United States and describe recommended actions for prevention and response. PATIENTS AND METHODS: We examined records of events involving communications to groups of patients, conducted from January 1, 2012, through December 31, 2018, in which bloodborne pathogen testing was recommended or offered because of potential exposure to unsafe injection practices by health care personnel in the United States. Information compiled included: health care setting(s), type of unsafe injection practice(s), number of patients notified, number of outbreak-associated infections, and whether evidence suggesting bloodborne pathogen transmission prompted the notification. We compared these numbers with a similar review conducted from January 1, 2001, through December 31, 2011. RESULTS: From 2012 through 2018, more than 66,748 patients were notified as part of 38 patient notification events. Twenty-one involved exposures in non-hospital settings. Twenty-five involved syringe and/or needle reuse in the context of routine patient care; 11 involved drug tampering by a health care provider. The majority of events (n=25) were prompted by identification of unsafe injection practices alone, absent any documented infections at the time of notification. Outbreak-associated hepatitis B virus and/or hepatitis C virus infections were documented for 11 of the events; 8 involved patient-to-patient transmission, and 3 involved provider-to-patient transmission. CONCLUSIONS: Since 2001, nearly 200,000 patients in the United States were notified about potential exposure to blood-contaminated medications or injection equipment. Facility leadership has an obligation to ensure adherence to safe injection practices and to respond properly if unsafe injection practices are identified. Published by Elsevier Inc.
OBJECTIVES: To summarize patient notifications resulting from unsafe injection practices by health care personnel in the United States and describe recommended actions for prevention and response. PATIENTS AND METHODS: We examined records of events involving communications to groups of patients, conducted from January 1, 2012, through December 31, 2018, in which bloodborne pathogen testing was recommended or offered because of potential exposure to unsafe injection practices by health care personnel in the United States. Information compiled included: health care setting(s), type of unsafe injection practice(s), number of patients notified, number of outbreak-associated infections, and whether evidence suggesting bloodborne pathogen transmission prompted the notification. We compared these numbers with a similar review conducted from January 1, 2001, through December 31, 2011. RESULTS: From 2012 through 2018, more than 66,748 patients were notified as part of 38 patient notification events. Twenty-one involved exposures in non-hospital settings. Twenty-five involved syringe and/or needle reuse in the context of routine patient care; 11 involved drug tampering by a health care provider. The majority of events (n=25) were prompted by identification of unsafe injection practices alone, absent any documented infections at the time of notification. Outbreak-associated hepatitis B virus and/or hepatitis C virus infections were documented for 11 of the events; 8 involved patient-to-patient transmission, and 3 involved provider-to-patient transmission. CONCLUSIONS: Since 2001, nearly 200,000 patients in the United States were notified about potential exposure to blood-contaminated medications or injection equipment. Facility leadership has an obligation to ensure adherence to safe injection practices and to respond properly if unsafe injection practices are identified. Published by Elsevier Inc.
Authors: Cassandra Johnston; Vidya Sunil; Dorothea Ser; Anne Marie Holt; Gary Garber; Liane Macdonald; Erik Kristjanson; Tony Mazzulli; Romy Olsha; David Ryding; Avis Lynn Noseworthy Journal: Can Commun Dis Rep Date: 2021-07-08
Authors: Melissa K Schaefer; Kiran M Perkins; Ruth Link-Gelles; Alexander J Kallen; Priti R Patel; Joseph F Perz Journal: Am J Infect Control Date: 2020-04-10 Impact factor: 2.918
Authors: Stacy R Tressler; Maria C Del Rosario; Michelle D Kirby; Ashley N Simmons; Melissa A Scott; Sherif Ibrahim; Joseph C Forbi; Hong Thai; Guo-Liang Xia; Meghan Lyman; Melissa G Collier; Priti R Patel; Danae Bixler Journal: Infect Control Hosp Epidemiol Date: 2021-03-01 Impact factor: 6.520